“…Studies have shown that individual genetic variants are associated with risk of substance abuse, including CD [but usually only in select populations, e.g., OPRM1 (Berrettini et al, 1997), Homer1 (Dahl et al, 2005), OPRD1 (Kreek et al, 2005; Crist et al, 2012)] but also that epigenetics may play a significant role in the disease process (e.g., Nielsen et al, 2009, 2010). Changes in epigenetics, including chromatin structure and DNA methylation, due to drug use, and the resulting change in gene expression are hypothesized to contribute to the neural plasticity in drug users that has long been considered a molecular mechanism through which drug addiction and relapse may occur (e.g., Berke et al, 1998; Nestler, 2001; Grimm et al, 2003; Yao et al, 2004; Shaham and Hope, 2005; Kalivas and O’Brien, 2008; Wong et al, 2011).…”